rs35400945

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000486.6(AQP2):​c.342G>A​(p.Gly114Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 1,605,498 control chromosomes in the GnomAD database, including 78 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 40 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 38 hom. )

Consequence

AQP2
NM_000486.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.755

Publications

0 publications found
Variant links:
Genes affected
AQP2 (HGNC:634): (aquaporin 2) This gene encodes a water channel protein located in the kidney collecting tubule. It belongs to the MIP/aquaporin family, some members of which are clustered together on chromosome 12q13. Mutations in this gene have been linked to autosomal dominant and recessive forms of nephrogenic diabetes insipidus. [provided by RefSeq, Oct 2008]
AQP2 Gene-Disease associations (from GenCC):
  • diabetes insipidus, nephrogenic, autosomal
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • nephrogenic diabetes insipidus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 12-49951172-G-A is Benign according to our data. Variant chr12-49951172-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 256241.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.755 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.012 (1829/152340) while in subpopulation AFR AF = 0.0419 (1742/41568). AF 95% confidence interval is 0.0403. There are 40 homozygotes in GnomAd4. There are 886 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 40 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AQP2NM_000486.6 linkc.342G>A p.Gly114Gly synonymous_variant Exon 1 of 4 ENST00000199280.4 NP_000477.1 P41181

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AQP2ENST00000199280.4 linkc.342G>A p.Gly114Gly synonymous_variant Exon 1 of 4 1 NM_000486.6 ENSP00000199280.3 P41181
AQP2ENST00000550862.1 linkc.342G>A p.Gly114Gly synonymous_variant Exon 1 of 3 5 ENSP00000450022.1 F8VPL3
AQP2ENST00000551526.5 linkn.342G>A non_coding_transcript_exon_variant Exon 1 of 6 5 ENSP00000447148.1 F8W0S2

Frequencies

GnomAD3 genomes
AF:
0.0120
AC:
1826
AN:
152222
Hom.:
40
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0420
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.00310
AC:
743
AN:
239856
AF XY:
0.00216
show subpopulations
Gnomad AFR exome
AF:
0.0422
Gnomad AMR exome
AF:
0.00201
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000130
Gnomad OTH exome
AF:
0.00205
GnomAD4 exome
AF:
0.00128
AC:
1853
AN:
1453158
Hom.:
38
Cov.:
30
AF XY:
0.00108
AC XY:
777
AN XY:
721988
show subpopulations
African (AFR)
AF:
0.0442
AC:
1474
AN:
33372
American (AMR)
AF:
0.00228
AC:
101
AN:
44220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25586
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39602
South Asian (SAS)
AF:
0.0000471
AC:
4
AN:
84886
European-Finnish (FIN)
AF:
0.0000192
AC:
1
AN:
52196
Middle Eastern (MID)
AF:
0.000873
AC:
5
AN:
5730
European-Non Finnish (NFE)
AF:
0.0000740
AC:
82
AN:
1107518
Other (OTH)
AF:
0.00310
AC:
186
AN:
60048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
106
212
318
424
530
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0120
AC:
1829
AN:
152340
Hom.:
40
Cov.:
33
AF XY:
0.0119
AC XY:
886
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0419
AC:
1742
AN:
41568
American (AMR)
AF:
0.00359
AC:
55
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68030
Other (OTH)
AF:
0.0109
AC:
23
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
93
186
279
372
465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00598
Hom.:
15
Bravo
AF:
0.0140
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 04, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Diabetes insipidus, nephrogenic, autosomal Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephrogenic diabetes insipidus Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
7.2
DANN
Benign
0.81
PhyloP100
-0.76
PromoterAI
0.021
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35400945; hg19: chr12-50344955; API